Try our mobile app

ИНН: 5047104371

E-disclosure page: 38933

Рост выручки hist 0.0%
Рост EBITDA hist 0.0%


млн руб
LTM Выручка 0
LTM EBITDA 0

Interest payment 0

Revenue and EBITDA

Quarterly values (m RUB)

Change (y/y)

Cash Flow

FCF (m RUB), before FX effects elimination

Net Debt / Cash and Equivalents (m RUB)

Облигации
Название ISIN Тип Доходность Валюта Цена Объем торгов (млн р.) Купон Ставка купона Премия Дата погашения/оферты Дюрация, лет
PLAZA BO01 RU000A106YD5 фикс +121.6% RUB 95.4% 0.26 42.8 17.2% - 2026-09-23 0.1
PLAZABO-02 RU000A108E80 фикс +78.9% RUB 57.2% 0.16 49.9 20.0% - 2028-05-09 1.7
RSBU data *The values are shown in mln. The % change shows the difference from the same period last year

View as Pivot Table       Export as Pivot Table (xlsx)



Income


Q Revenue Gross profit Operating income Net income PercentProfit PercentLoss
 
2026 q2 105+1% 65-2% -4<-100% 10<-100% 1+19% -14-8%
2026 q1 115+1% 75+5% 5-28% -10-1% 1+79% -14-2%
2025 q4 1420% 94+8% 26+60% 7<-100% 1+140% -13-4%
2025 q3 132+13% 90+24% 29+150% 5+100% 1+24% -15+7%
2025 q2 104-15% 67-12% 7-63% 0<-100% 1+29% -15+27%
2025 q1 113-4% 71-1% 7-51% -10<-100% 0-56% -14+32%
2024 q4 142+8% 87+11% 16-24% 0<-100% 0+108% -14+41%
2024 q3 116+21% 72+26% 12+29% 0<-100% 0 -14+150%
2024 q2 123+29% 76+34% 18+67% 2-33% 0>+200% -12+158%
2024 q1 119+27% 71+25% 15+64% 0-80% 1 -11+144%
2023 q4 131+43% 78+42% 21>+200% 4>+200% 0 -10>+200%
2023 q3 96 57 9 1   -6
2023 q2 95 57 11 3 0 -4
2023 q1 93 57 9 2   -4
2022 q4 91 55 6 1   -3


Balance


Implied interest rate for 2026 q2:
= (PercentLoss - PercentProfit) * (365 / periodLength) / (NetDebt - MinorityInterest)
= (14 - 1) * 4 / (318 - 0)

Q Total equity Total assets Net debt
 
2026 q2 78+19% 585+3% 3180%
2026 q1 67+2% 582+4% 306+3%
2025 q4 77+2% 588+7% 308+4%
2025 q3 710%   319+7%
2025 q2 66-10% 567+23% 317+8%
2025 q1 66-12% 561+25% 298+11%
2024 q4 76-26% 548+25% 296+43%
2024 q3 70 461 297
2024 q2 73 461 293
2024 q1 75 449 269
2023 q4 102 439 208+40%
2023 q3      
2023 q2      
2023 q1      
2022 q4     148

RAS reports